These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29715320)

  • 1. Deciphering the binding behavior of flavonoids to the cyclin dependent kinase 6/cyclin D complex.
    Zhang J; Zhang L; Xu Y; Jiang S; Shao Y
    PLoS One; 2018; 13(5):e0196651. PubMed ID: 29715320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular dynamic behavior and binding affinity of flavonoid analogues to the cyclin dependent kinase 6/cyclin D complex.
    Khuntawee W; Rungrotmongkol T; Hannongbua S
    J Chem Inf Model; 2012 Jan; 52(1):76-83. PubMed ID: 22172011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin.
    Lu H; Chang DJ; Baratte B; Meijer L; Schulze-Gahmen U
    J Med Chem; 2005 Feb; 48(3):737-43. PubMed ID: 15689157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of new small-molecule cyclin-dependent kinase 6 inhibitors through computational approaches.
    Luo X; Zhao Y; Tang P; Du X; Li F; Wang Q; Li R; He J
    Mol Divers; 2021 Feb; 25(1):367-382. PubMed ID: 32770459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A theoretical study on the hydrogen-bonding interactions between flavonoids and ethanol/water.
    Zheng YZ; Zhou Y; Liang Q; Chen DF; Guo R
    J Mol Model; 2016 Apr; 22(4):95. PubMed ID: 27029620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galangin inhibits growth of human head and neck squamous carcinoma cells in vitro and in vivo.
    Zhu L; Luo Q; Bi J; Ding J; Ge S; Chen F
    Chem Biol Interact; 2014 Dec; 224():149-56. PubMed ID: 25450235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced state transition barrier of CDK6 from open to closed state induced by Thr177 phosphorylation and its implication in binding modes of inhibitors.
    He H; Xu J; Xie W; Guo QL; Jiang FL; Liu Y
    Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):501-512. PubMed ID: 29108955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlling cell proliferation by targeting cyclin-dependent kinase 6 using drug repurposing approach.
    Madhana Priya N; Balasundaram A; Sidharth Kumar N; Udhaya Kumar S; Thirumal Kumar D; Magesh R; Zayed H; George Priya Doss C
    Adv Protein Chem Struct Biol; 2023; 135():97-124. PubMed ID: 37061342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D-CDK4/6 functions in cancer.
    Gao X; Leone GW; Wang H
    Adv Cancer Res; 2020; 148():147-169. PubMed ID: 32723562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring therapeutic potential of Rutin by investigating its cyclin-dependent kinase 6 inhibitory activity and binding affinity.
    Yousuf M; Khan S; Hussain A; Alajmi MF; Shamsi A; Haque QMR; Islam A; Hassan MI
    Int J Biol Macromol; 2024 Apr; 264(Pt 2):130624. PubMed ID: 38453105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cyclin D-CDK6 dimer helps to reshuffle cyclin-dependent kinase inhibitors (CKI) to overcome TGF-beta-mediated arrest and maintain CDK2 activity.
    Nataraj SE; Blain SW
    Cell Cycle; 2021 Apr; 20(8):808-818. PubMed ID: 33794722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK; Medina D
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of phenolic OH groups of flavonoid compounds with H-bond formation ability to suppress amyloid mature fibrils by destabilizing β-sheet conformation of monomeric Aβ17-42.
    Andarzi Gargari S; Barzegar A; Tarinejad A
    PLoS One; 2018; 13(6):e0199541. PubMed ID: 29953467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lineage specific composition of cyclin D-CDK4/CDK6-p27 complexes reveals distinct functions of CDK4, CDK6 and individual D-type cyclins in differentiating cells of embryonic origin.
    Bryja V; Pacherník J; Vondráček J; Souček K; Čajánek L; Horvath V; Holubcová Z; Dvořák P; Hampl A
    Cell Prolif; 2008 Dec; 41(6):875-893. PubMed ID: 19040567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for CDK6 activation by a virus-encoded cyclin.
    Schulze-Gahmen U; Kim SH
    Nat Struct Biol; 2002 Mar; 9(3):177-81. PubMed ID: 11828325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of human beta-cell proliferation and engraftment using a single G1/S regulatory molecule, cdk6.
    Fiaschi-Taesch NM; Salim F; Kleinberger J; Troxell R; Cozar-Castellano I; Selk K; Cherok E; Takane KK; Scott DK; Stewart AF
    Diabetes; 2010 Aug; 59(8):1926-36. PubMed ID: 20668294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Pathways: Targeting the Cyclin D-CDK4/6 Axis for Cancer Treatment.
    VanArsdale T; Boshoff C; Arndt KT; Abraham RT
    Clin Cancer Res; 2015 Jul; 21(13):2905-10. PubMed ID: 25941111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GRID and docking analyses reveal a molecular basis for flavonoid inhibition of Src family kinase activity.
    Wright B; Watson KA; McGuffin LJ; Lovegrove JA; Gibbins JM
    J Nutr Biochem; 2015 Nov; 26(11):1156-65. PubMed ID: 26140983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma.
    Easton J; Wei T; Lahti JM; Kidd VJ
    Cancer Res; 1998 Jun; 58(12):2624-32. PubMed ID: 9635589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing CDK4/6-p16(INK4a) interface. Computational alanine scanning of a peptide bound to CDK6 protein.
    Villacañas O; Rubio-Martinez J
    Proteins; 2006 Jun; 63(4):797-810. PubMed ID: 16508961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.